Both [99mTc]Tc-ADAPT6 and [99mTc]Tc-(HE)3-G3 were capable of visualizing HER2-expressing breast cancer lesions, including primary tumours, lymph node metastases and, in two patients, hepatic metastases. Here, ERBB2 is linked to metastatic malignant neoplasm in the lymph nodes.